Navigation Links
Mayor Greg Ballard to Join Roche Diagnostics Leaders at Groundbreaking of New Learning and Development Center

INDIANAPOLIS, Nov. 12, 2012 /PRNewswire/ -- Roche Diagnostics, a world leader in pharmaceuticals and diagnostics, announced in June its plans to invest $300 million during the next 10 years in expanding its North American headquarters located on the northeast side of Indianapolis.  The first phase of the project is a new Learning and Development Center, where approximately 1,500 customers from across the nation will be trained each year. 

Mayor Greg Ballard will be joined by Roche Diagnostics President and CEO Jack Phillips along with members of the City-County Council and community leaders to break ground on the expansion and unveil renderings of the new building, which will have a distinct architectural style.  WHO: Mayor Greg BallardJack Phillips, President and CEO, Roche DiagnosticsMembers of City-County CouncilWHEN:Wednesday, November 14, 201210:00 A.M. Eastern Standard TimeWHAT:Groundbreaking Ceremony for Roche Diagnostics Learning and Development CenterWHERE:Roche Diagnostics Campus – Near Entrance 49115 Hague Road, Indianapolis, IndianaRSVP:Please RSVP to Jacque Robertson at or (317) 521-2819Due to limited parking on corporate campus, RSVPs are appreciated.NOTE:Press riser with mult box to be provided.  Principals will be made available to press following event. About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information:

All trademarks used or mentioned in this release are protected by law.For further information, please contact: Todd Siesky Director, Corporate Communications

Roche Diagnostics

Indianapolis, IN(317) 521-3966 O

(317) 361-7637


SOURCE Roche Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New York City Mayor Bloomberg and Health Commissioner Farley Receive Flu Shot at Duane Reade Pharmacy, Highlight Importance of Flu Preparedness
2. Rochester Medical Corporation Announces Decision To Exit The Foley Catheter Business
3. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
4. Roche cytomegalovirus viral load test now available in US
5. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
6. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
7. Rochester Medical Reports Third Quarter Results
8. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
9. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
10. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
11. Roche announces FDA approval of HIV viral load test
Post Your Comments:
(Date:10/13/2015)... Calif. , Oct. 13, 2015  SRI ... up to $100 million over five years by ... (NIAID), part of the National Institutes of Health, ... treat acute or delayed effects of radiation exposure. ... a division of SRI International will provide services, ...
(Date:10/13/2015)... , Oct. 13 2015 ... the addition of the "US & ... 16 Countries (2010-2021)" report to their ... announced the addition of the "US ... - 16 Countries (2010-2021)" report to ...
(Date:10/13/2015)... 13, 2015 anesthesia and respiratory ... billion by 2022, according to a new report by ... to their capability to resolve various environmental and lifestyle ... growth. --> anesthesia and respiratory devices market ... 2022, according to a new report by Grand View ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... ... Scientists in Seattle and Vancouver compared the diagnostic value of lung fluid cytology ... has just posted an article on the new research. Click here to read ... of British Columbia found that certain genetic alterations were seen just as often in ...
(Date:10/13/2015)... ... October 13, 2015 , ... Tempe Dental Care, a leading Tempe ... and IV sedation dentistry for more than 5 years. A leading cause ... serious and painful if treatment is not timely. , Sedation dentistry ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... Local Gold’s ... Gold’s Gym International Conference on August 26. Berry, who owns and operates Gold's ... for the fastest growing Gold’s Gyms in the United States. A brand leader in ...
(Date:10/13/2015)... ... October 13, 2015 , ... Thermi, an ... newest professional to introduce the latest development, ThermiVa® temperature controlled radiofrequency to the ... professional in Obstetrics and Gynecology and a pioneer in the field of laparoscopy. ...
(Date:10/13/2015)... ... October 13, 2015 , ... In an ongoing effort ... , a Southlake, Texas, child development and pediatric therapy center, is working with ... families about their options for receiving this kind of care for affected children. ...
Breaking Medicine News(10 mins):